Gene: ITPR3

3710
IP3R|IP3R3
inositol 1,4,5-trisphosphate receptor type 3
protein-coding
6p21.31
Ensembl:ENSG00000096433 MIM:147267 Vega:OTTHUMG00000014532 UniprotKB:Q14573
NG_027729.1
PubMed
ND
1   
NA (AD)  NA (ND)   (Frontal_Cortex)
3.450e-2 (AD)  8.632e-1 (ND)

DNA Methylation

Probe Locus(GRCh37) Gene Region p-val Trait PubMed ID
cg17865955chr6:33601177ITPR37.000e-10Alcohol consumption der day27843151

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
PODXL0.86
MYO1C0.854
ADCY40.849
NBEAL20.848
PKN30.847
NOS30.843
ACVRL10.84
MMRN20.84
LAMC10.835
CDH50.83

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
CRH-0.375
C1orf53-0.331
SMIM18-0.327
ALG1L-0.311
ZSCAN1-0.305
ASPDH-0.303
CPLX3-0.297
ARSF-0.291
MYADML2-0.288
MYCNOS-0.287

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C1099862-aminoethoxydiphenyl borate2-aminoethoxydiphenyl borate binds to and results in decreased activity of ITPR3 protein15245872
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ITPR3 mRNA"23196670
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITPR3 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITPR3 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITPR3 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITPR3 mRNA"27188386
D000082AcetaminophenAcetaminophen results in increased expression of ITPR3 mRNA26690555
D000082AcetaminophenAcetaminophen affects the expression of ITPR3 mRNA17562736
C085029adenophostin Aadenophostin A analog binds to and results in increased activity of ITPR3 protein18247493
C085029adenophostin Aadenophostin A binds to and results in increased activity of ITPR3 protein18247493
D000643Ammonium ChlorideAmmonium Chloride affects the expression of ITPR3 mRNA16483693
D018501Antirheumatic AgentsAntirheumatic Agents results in decreased expression of ITPR3 mRNA24449571
D001280AtrazineAtrazine results in decreased expression of ITPR3 mRNA25929836
D001280AtrazineAtrazine results in increased expression of ITPR3 mRNA22378314
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of ITPR3 mRNA22316170
D004958EstradiolEstradiol affects the expression of ITPR3 mRNA23557687
C543008bis(4-hydroxyphenyl)sulfone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ITPR3 mRNA28628672
C551172bis-N,N-dimethylamino-2-(N-methylpyrrolyl)methyl cyclopentadienyl titanium (IV)"bis-N,N-dimethylamino-2-(N-methylpyrrolyl)methyl cyclopentadienyl titanium (IV) results in increased expression of ITPR3 mRNA"20162321
C006780bisphenol Abisphenol A affects the expression of ITPR3 mRNA21786754
C006780bisphenol Abisphenol A results in increased expression of ITPR3 mRNA29027980
C006780bisphenol Abisphenol A affects the expression of ITPR3 mRNA25181051
C006780bisphenol Abisphenol A results in increased expression of ITPR3 protein24552547
C000611646bisphenol F[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ITPR3 mRNA28628672
D020122tert-Butylhydroperoxidetert-Butylhydroperoxide affects the expression of ITPR3 mRNA23410634
D019256Cadmium ChlorideCadmium Chloride results in increased expression of ITPR3 mRNA24982889
D002118CalciumCalcium affects the expression of ITPR3 protein10963052
D002713Chlorine[Ozone co-treated with Chlorine] results in increased expression of ITPR3 mRNA18636392
D020111Chlorodiphenyl (54% Chlorine)Chlorodiphenyl (54% Chlorine) results in increased expression of ITPR3 mRNA25270620
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ITPR3 mRNA20938992
D002994ClofibrateClofibrate results in increased expression of ITPR3 mRNA25270620
C018021cobaltous chloridecobaltous chloride results in decreased expression of ITPR3 mRNA19376846
D019327Copper SulfateCopper Sulfate results in increased expression of ITPR3 mRNA19549813
D016572CyclosporineCyclosporine results in increased expression of ITPR3 mRNA20106945|2163298
C014347decitabinedecitabine affects the expression of ITPR3 mRNA23300844
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ITPR3 mRNA28628672
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ITPR3 mRNA28628672
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ITPR3 mRNA28628672
D003993Dibutyl PhthalateDibutyl Phthalate results in decreased expression of ITPR3 mRNA21266533
D002945CisplatinCisplatin affects the expression of ITPR3 mRNA23300844
D002945CisplatinCisplatin results in increased expression of ITPR3 mRNA21151649
C036042dicyclohexyl phthalatedicyclohexyl phthalate affects the expression of ITPR3 mRNA26924002
D004041Dietary FatsDietary Fats results in increased expression of ITPR3 mRNA18042831
C118739entinostatentinostat results in increased expression of ITPR3 mRNA26272509|2718838
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITPR3 mRNA"27188386
C017690fenvaleratefenvalerate results in increased expression of ITPR3 mRNA19428952
D005419FlavonoidsFlavonoids results in increased expression of ITPR3 mRNA18035473
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ITPR3 mRNA20938992
C069837fullerene C60fullerene C60 results in increased expression of ITPR3 mRNA19167457
D019833Genistein[Genistein co-treated with Methoxychlor] results in decreased expression of ITPR3 mRNA21782745
D006534Heptachlor EpoxideHeptachlor Epoxide results in increased expression of ITPR3 mRNA25270620
D017313FenretinideFenretinide results in increased expression of ITPR3 mRNA28973697
D006861Hydrogen PeroxideHydrogen Peroxide affects the expression of ITPR3 mRNA20044591|2341063
C492448ICG 001ICG 001 results in increased expression of ITPR3 mRNA26191083
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ITPR3 mRNA28628672
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ITPR3 mRNA28628672
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ITPR3 mRNA28628672
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of ITPR3 mRNA25613284
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ITPR3 mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ITPR3 mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ITPR3 mRNA28628672
C544151jinfukangjinfukang results in increased expression of ITPR3 mRNA27392435
C098607JP8 aviation fuelJP8 aviation fuel results in decreased expression of ITPR3 protein17337753
C561695(+)-JQ1 compound(+)-JQ1 compound results in decreased expression of ITPR3 mRNA24796395
C045463leflunomideleflunomide results in increased expression of ITPR3 mRNA28988120
C002385linsidominelinsidomine results in increased oxidation of ITPR3 protein28086193
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ITPR3 mRNA20938992
D008727MethotrexateMethotrexate results in increased expression of ITPR3 mRNA21678067
D008731Methoxychlor[Genistein co-treated with Methoxychlor] results in decreased expression of ITPR3 mRNA21782745
C517284monomethyl phthalatemonomethyl phthalate affects the expression of ITPR3 mRNA26924002
C017096n-butoxyethanoln-butoxyethanol results in decreased expression of ITPR3 mRNA19812364
C028007nickel monoxidenickel monoxide results in increased expression of ITPR3 mRNA19167457
C029938nickel sulfatenickel sulfate results in increased expression of ITPR3 mRNA22714537
D010126Ozone[Ozone co-treated with Chlorine] results in increased expression of ITPR3 mRNA18636392
D000073878Palm OilPalm Oil results in increased expression of ITPR3 mRNA18042831
D052638Particulate MatterParticulate Matter results in increased expression of ITPR3 mRNA28412507
C086401pentabromodiphenyl etherpentabromodiphenyl ether results in increased expression of ITPR3 mRNA26705709
D010634PhenobarbitalNR1I3 protein affects the reaction [Phenobarbital results in increased expression of ITPR3 mRNA]19482888
D010634PhenobarbitalPhenobarbital results in increased expression of ITPR3 mRNA19482888
C006253pirinixic acid[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ITPR3 mRNA19710929
C006253pirinixic acidpirinixic acid results in decreased expression of ITPR3 mRNA17426115
D011794QuercetinQuercetin results in increased expression of ITPR3 mRNA21632981
D020849Raloxifene HydrochlorideRaloxifene Hydrochloride affects the expression of ITPR3 mRNA14699072
C059514resveratrolresveratrol results in increased phosphorylation of ITPR3 protein25311616
C017947sodium arsenitesodium arsenite results in increased expression of ITPR3 protein19072884
C061133tamibarotenetamibarotene results in decreased expression of ITPR3 mRNA15498508
D013629TamoxifenTamoxifen affects the expression of ITPR3 mRNA14699072
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of ITPR3 mRNA21570461
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of ITPR3 mRNA25613284
D019284ThapsigarginThapsigargin results in decreased expression of ITPR3 mRNA22378314
D013849ThimerosalThimerosal results in decreased expression of ITPR3 mRNA27188386
D014212TretinoinTretinoin results in decreased expression of ITPR3 mRNA15498508|2193413
D014212TretinoinTretinoin results in increased expression of ITPR3 mRNA20488242
C012589trichostatin Atrichostatin A results in increased expression of ITPR3 mRNA24935251
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in increased expression of ITPR3 mRNA"26179874
C013320tris(2-butoxyethyl) phosphatetris(2-butoxyethyl) phosphate affects the expression of ITPR3 mRNA29024780
C022884undecaneundecane results in decreased expression of ITPR3 protein17337753
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITPR3 mRNA"27188386
D014635Valproic AcidValproic Acid affects the expression of ITPR3 mRNA25979313
D014635Valproic AcidValproic Acid results in increased expression of ITPR3 mRNA19101580|2317975
C034028vanadyl sulfatevanadyl sulfate results in increased expression of ITPR3 mRNA16330358
D001335Vehicle EmissionsVehicle Emissions results in decreased methylation of ITPR3 gene25560391
C025643vinclozolinvinclozolin results in decreased expression of ITPR3 mRNA23034163
C029297vinylidene chloridevinylidene chloride results in increased expression of ITPR3 mRNA26682919
D024483Vitamin K 3Vitamin K 3 affects the expression of ITPR3 mRNA20044591|2341063

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0000822inositol hexakisphosphate binding-ISS-  
GO:0005220inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity-IBA21873635  
GO:0005220inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity-IDA10828023  
GO:0005220inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity-ISS-  
GO:0005509calcium ion binding-IBA21873635  
GO:0005515protein binding-IPI10611319  19052258  19553469  21062895  25996873  
GO:0015278calcium-release channel activity-ISS-  
GO:0035091phosphatidylinositol binding-IBA21873635  
GO:0035091phosphatidylinositol binding-IEA-  
GO:0043533inositol 1,3,4,5 tetrakisphosphate binding-ISS-  
GO:0070679inositol 1,4,5 trisphosphate binding-IBA21873635  
GO:0070679inositol 1,4,5 trisphosphate binding-IDA8288584  
GO ID GO Term Qualifier Evidence PubMed
GO:0007186G-protein coupled receptor signaling pathway-ISS-  
GO:0007204positive regulation of cytosolic calcium ion concentration-ISS-  
GO:0007613memory-IEA-  
GO:0030168platelet activation-TAS-  
GO:0048016inositol phosphate-mediated signaling-IEA-  
GO:0050796regulation of insulin secretion-TAS-  
GO:0050913sensory perception of bitter taste-IEA-  
GO:0050916sensory perception of sweet taste-IEA-  
GO:0050917sensory perception of umami taste-IEA-  
GO:0051209release of sequestered calcium ion into cytosol-IBA21873635  
GO:0051209release of sequestered calcium ion into cytosol-IEA-  
GO:0051260protein homooligomerization-ISS-  
GO:0051291protein heterooligomerization-ISS-  
GO:0051592response to calcium ion-IDA19052258  
GO:0060291long-term synaptic potentiation-IEA-  
GO:0060402calcium ion transport into cytosol-ISS-  
GO:1903779regulation of cardiac conduction-TAS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005640nuclear outer membrane-ISS-  
GO:0005654nucleoplasm-IEA-  
GO:0005730nucleolus-IEA-  
GO:0005737cytoplasm-ISS-  
GO:0005783endoplasmic reticulum-ISS-  
GO:0005789endoplasmic reticulum membrane-IBA21873635  
GO:0005789endoplasmic reticulum membrane-IDA21062895  
GO:0005789endoplasmic reticulum membrane-ISS-  
GO:0005789endoplasmic reticulum membrane-TAS-  
GO:0005886plasma membrane-IBA21873635  
GO:0005886plasma membrane-IDA21062895  
GO:0005887integral component of plasma membrane-IDA10828023  
GO:0005903brush border-ISS8288584  
GO:0016020membrane-HDA19946888  
GO:0016529sarcoplasmic reticulum-IBA21873635  
GO:0030659cytoplasmic vesicle membrane-IBA21873635  
GO:0030667secretory granule membrane-IBA21873635  
GO:0031095platelet dense tubular network membrane-TAS-  
GO:0043025neuronal cell body-ISS-  
GO:0043209myelin sheath-ISS-  
GO:0043235receptor complex-IDA23382219  
GO:0045177apical part of cell-ISS8288584  
KEGG ID KEGG Term
hsa04020Calcium signaling pathway
hsa04070Phosphatidylinositol signaling system
hsa04114Oocyte meiosis
hsa04270Vascular smooth muscle contraction
hsa04540Gap junction
hsa04720Long-term potentiation
hsa04730Long-term depression
hsa04742Taste transduction
hsa04912GnRH signaling pathway
hsa04970Salivary secretion
hsa04971Gastric acid secretion
hsa04972Pancreatic secretion
hsa05010Alzheimer's disease
Reactome ID Reactome Term Evidence
R-HSA-109582HemostasisTAS
R-HSA-111885Opioid SignallingIEA
R-HSA-112040G-protein mediated eventsIEA
R-HSA-112043PLC beta mediated eventsIEA
R-HSA-114508Effects of PIP2 hydrolysisTAS
R-HSA-1280218Adaptive Immune SystemIEA
R-HSA-1280218Adaptive Immune SystemTAS
R-HSA-139853Elevation of cytosolic Ca2+ levelsTAS
R-HSA-1430728MetabolismIEA
R-HSA-1430728MetabolismTAS
R-HSA-1489509DAG and IP3 signalingIEA
R-HSA-162582Signal TransductionIEA
R-HSA-162582Signal TransductionTAS
R-HSA-163685Integration of energy metabolismIEA
R-HSA-163685Integration of energy metabolismTAS
R-HSA-168249Innate Immune SystemIEA
R-HSA-168256Immune SystemIEA
R-HSA-168256Immune SystemTAS
R-HSA-194138Signaling by VEGFIEA
R-HSA-195721Signaling by WNTIEA
R-HSA-2029480Fcgamma receptor (FCGR) dependent phagocytosisIEA
R-HSA-2029485Role of phospholipids in phagocytosisIEA
R-HSA-2454202Fc epsilon receptor (FCERI) signalingIEA
R-HSA-2871809FCERI mediated Ca+2 mobilizationIEA
R-HSA-372790Signaling by GPCRIEA
R-HSA-372790Signaling by GPCRTAS
R-HSA-381676Glucagon-like Peptide-1 (GLP1) regulates insulin secretionTAS
R-HSA-3858494Beta-catenin independent WNT signalingIEA
R-HSA-388396GPCR downstream signallingIEA
R-HSA-388396GPCR downstream signallingTAS
R-HSA-397014Muscle contractionIEA
R-HSA-397014Muscle contractionTAS
R-HSA-4086398Ca2+ pathwayIEA
R-HSA-416476G alpha (q) signalling eventsTAS
R-HSA-418346Platelet homeostasisTAS
R-HSA-418360Platelet calcium homeostasisTAS
R-HSA-418594G alpha (i) signalling eventsIEA
R-HSA-422356Regulation of insulin secretionIEA
R-HSA-422356Regulation of insulin secretionTAS
R-HSA-4420097VEGFA-VEGFR2 PathwayIEA
R-HSA-5218921VEGFR2 mediated cell proliferationIEA
R-HSA-5576891Cardiac conductionIEA
R-HSA-5576891Cardiac conductionTAS
R-HSA-5578775Ion homeostasisIEA
R-HSA-5578775Ion homeostasisTAS
R-HSA-5607763CLEC7A (Dectin-1) induces NFAT activationIEA
R-HSA-5607764CLEC7A (Dectin-1) signalingIEA
R-HSA-5621481C-type lectin receptors (CLRs)IEA
R-HSA-76002Platelet activation, signaling and aggregationTAS
R-HSA-9006925Intracellular signaling by second messengersIEA
R-HSA-9006934Signaling by Receptor Tyrosine KinasesIEA
R-HSA-983695Antigen activates B Cell Receptor (BCR) leading to generation of second messengersIEA
R-HSA-983695Antigen activates B Cell Receptor (BCR) leading to generation of second messengersTAS
R-HSA-983705Signaling by the B Cell Receptor (BCR)IEA
R-HSA-983705Signaling by the B Cell Receptor (BCR)TAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
28193307Heritability and GWAS Studies for Monocyte-Lymphocyte Ratio. (2017 Apr)Lin BDTwin Res Hum Genet